Conclusions
PD-1/PD-L1 immune antibodies alone or with conventional treatments may prolong the OS of participants with HNC and caused fewer AEs except for hypothyroidism. Besides, patients with HPV positive and or PD-L1 CPS≥1 had a lower risk of death, while no statistical differences in ORR and DCR were observed between different HPV status and experimental groups and control groups.